Plant Health Care plc Company Profile (LON:PHC)

Analyst Ratings

Consensus Ratings for Plant Health Care plc (LON:PHC) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 120

Analysts' Ratings History for Plant Health Care plc (LON:PHC)
Show:
DateFirmActionRatingPrice TargetActions
6/7/2016Liberum CapitalReiterated RatingBuyGBX 120View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2015Northland SecuritiesReiterated RatingHoldGBX 75View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/27/2014Landsbanki SecuritiesReiterated RatingHoldGBX 75View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Plant Health Care plc (LON:PHC)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Plant Health Care plc (LON:PHC)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Plant Health Care plc (LON:PHC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Plant Health Care plc (LON:PHC)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Plant Health Care plc (LON:PHC)
DateHeadline
07/20/16 06:37 PMKill pills,grow herbs
07/10/16 05:07 PM13 life-saving ambulances, trauma centre for State
07/05/16 10:18 AMInvesting In Local Vaccines
06/27/16 05:49 PMMy mandate’s to deliver effective primary health care services – Edu
06/08/16 08:51 AMPlant Health Care ( PHC )
06/07/16 08:34 AMPHC says progress on new tech builds momentum
06/07/16 08:34 AMFTSE 100 Index rises as Herencia gets in the money
06/07/16 08:34 AMPlant Health Expects At Least One Platform To Make Revenue In 2017
06/07/16 01:18 AMProgress on New Technology Builds Momentum - [at noodls] - PLANT HEALTH CARE PLC ('Plant Health Care' or the 'Company') Plant Health Care (AIM: PHC), a leading provider of novel patent-protected biological products to global agriculture markets, today commented ...
04/22/16 01:40 AMPlant Health Care Plc :PHC-GB: Earnings Analysis: For the six months ended December 31, 2015 -
04/22/16 01:11 AMPlant Health Care Plc :PHC-GB: Earnings Analysis: 2015 By the Numbers -
04/08/16 11:40 AMRevenue, gross profit up at Plant Health Care -
01/14/16 10:24 AMBoard changes and trading update - [at noodls] - PLANT HEALTH CARE plc ("Plant Health Care" or the "Company") Plant Health Care announces organisation changes and a pre-close trading statement in respect of the year ended 31 December ...
01/14/16 10:24 AMBlocklisting Interim Review - [at noodls] - BLOCK LISTING SIX-MONTHLY RETURN Date: 19 February 2015 Name of applicant : Plant Health Care plc Name of scheme: Plant Health Care, Inc. 2001 Equity Incentive Plan ... This is an abstract of the original ...
01/14/16 10:24 AMAnnual Financial Report - [at noodls] - RNS Number : 7737I Plant Health Care PLC 30 March 2015 RNS 30th March 2015 PRELIMINARY RESULTS 2014 Plant Health Care (AIM: PHC), a leading provider of novel patent-protected biological products to the ...
01/14/16 10:24 AMRe Agreement - [at noodls] - PLANT HEALTH CARE plc ("Plant Health Care" or the "Company") Plant Health Care Signs First Innatus ™ 3G Evaluation Agreement With Major Industry Player Company Continues To Expand R&D ...
12/02/15 03:47 AMPlant Health Care expands US distribution arrangements -
07/13/15 09:22 AMPlant Health Care receives first product registration in Brazil -

Social

About Plant Health Care plc

Plant Health Care plc logoPlant healthcare plc is an agricultural bio-technology company. The Company provides biological products for the agricultural markets. The Company's bio-stimulants are products, which mobilize plants to increase yields and to defend themselves against attack by pests or from the debilitating effects of drought. The Company's brands include Myconate, Harpin, ProAct, N-Hibit and Innatus. The Company's products consist of three segments: Europe, Mexico and the United States. The Company operates its business in two areas: discovery and commercial products. The Company's discovery area is focused on the discovery and evaluation of bio-stimulants, which it intends to license to companies for further development, registration and sale. The Company's commercial products area is focused on the commercialization and sale of bio-stimulant and related products.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: PHC
  • CUSIP:
Key Metrics:
  • Previous Close: $0.30
  • 50 Day Moving Average: $31.84
  • 200 Day Moving Average: $55.83
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $16.17M
  • Current Year EPS Consensus Estimate: $-0.11 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: